Business Context and Reporting Period
Company: Ocular Therapeutix, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 10, 2015
Reporting Period: Quarter ended June 30, 2015
Context: The Company filed this report to announce its financial results for the second quarter of 2015. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text serves as a notification of the results and incorporates the press release by reference. It does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for these metrics.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached Exhibit 99.1 (Press Release) for comparative analysis.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, management commentary, risks, contingencies, or unusual items. These details are located within the referenced press release (Exhibit 99.1).
Important Facts for Investor Verification
- Verify the specific financial figures (revenue, net loss, cash position) in the attached Exhibit 99.1 press release, as they are not listed in the 8-K body.
- Confirm the status of the Company's clinical trials and product development pipeline as of June 30, 2015, which are typically detailed in the quarterly press release.
- Note that the information in this 8-K is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, limiting liability exposure for the specific data points.